1. Subtype-Specific Tumour Immune Microenvironment in Risk of Recurrence of Ductal Carcinoma In Situ: Prognostic Value of HER2
   Julia Solek et al, 2022, Biomedicines CrossRef
2. Impact of Surgical Delay on Tumor Upstaging and Outcomes in Estrogen Receptor–Negative Ductal Carcinoma in Situ Patients
   Amanda E Deliere et al, 2022, Journal of the American College of Surgeons CrossRef
3. Predicting Upgrade of Ductal Carcinoma In Situ to Invasive Breast Cancer at Surgery With Ultrafast Imaging
   Rachel Miceli et al, 2023, American Journal of Roentgenology CrossRef
4. Magnetic resonance imaging diagnosis of non-mass enhancement of the breast
   Kazunori Kubota et al, 2023, Journal of Medical Ultrasonics CrossRef
5. Deep‐learning model to improve histological grading and predict upstaging of atypical ductal hyperplasia / ductal carcinoma in situ on breast biopsy
   Chung‐Yen Huang et al, 2024, Histopathology CrossRef
6. Breast cancer in Trinidad and Tobago: Etiopathogenesis, histopathology and receptor study
   VijayKumar Chattu et al, 2021, Journal of Family Medicine and Primary Care CrossRef